周四盘中，生物科技公司Moderna, Inc.（MRNA）股价大幅下跌10.20%，引发投资者关注。这一跌势并非孤立事件，而是反映了整个医药行业的普遍走低趋势。
据市场数据显示，医药板块多家知名企业股价均出现明显下跌。其中，诺瓦瓦克斯医药（NVAX）跌幅最为显著，超过21%；默沙东（MRK）和礼来（LLY）分别下跌超过5%和5.8%；辉瑞（PFE）也下跌超过4%。这种普遍性下跌趋势表明，可能存在影响整个行业的宏观因素。
尽管目前尚未有具体消息解释这波跌势的原因，但分析人士推测，可能与市场对医药行业整体前景的担忧有关。投资者可能正在重新评估疫情后医药公司的增长潜力，或者对行业面临的监管压力和药品定价问题表示担忧。此外，全球经济不确定性增加，也可能促使投资者从传统被视为防御性板块的医药股中撤资。投资者应密切关注后续可能出现的行业相关政策或重大事件，以更好地理解这一波股价变动的深层原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.